Related Experiment Video
Updated: Jun 18, 2026

O-Ring Aortic Banding Versus Traditional Transverse Aortic Constriction for Modeling Pressure Overload-Induced Cardiac Hypertrophy
Published on: October 6, 2022
Hypertension in aortic coarctation
1Department of Pediatric Cardiology and Congenital Heart Disease, Deutsches Herzzentrum München, Technische Universität München, Germany. a-hager@web.de
Insights
Patients with aortic coarctation often develop hypertension through distinct pathways. Understanding these, including re-stenosis, paradoxical, and late hypertension, is crucial for effective patient treatment and improved outcomes.
Area of Science:
- Cardiology
- Vascular Medicine
- Hypertension Research
Background:
- Aortic coarctation (CoA) is a congenital heart defect associated with significant long-term cardiovascular risks.
- Arterial hypertension is a common and serious complication in patients with repaired or unrepaired CoA.
- Hypertension-related complications are a leading cause of mortality in the CoA population.
Purpose of the Study:
- To review and synthesize current knowledge on the different pathophysiologic pathways of hypertension in aortic coarctation patients.
- To provide guidance on differentiating these distinct hypertensive pathways.
- To outline appropriate treatment strategies for each identified pathway.
Main Methods:
- Systematic review of existing literature on aortic coarctation and associated hypertension.
- Analysis of pathophysiologic mechanisms underlying re-stenosis, paradoxical hypertension, and late-onset hypertension.
- Evaluation of diagnostic criteria and clinical approaches for differentiating hypertensive pathways.
- Summary of current evidence-based treatment guidelines.
Main Results:
- Identified three primary pathophysiologic pathways leading to hypertension in CoA patients: aortic isthmus re-stenosis, paradoxical hypertension, and late hypertension.
- Highlighted key clinical and diagnostic features that distinguish each pathway.
- Emphasized the direct link between hypertension and mortality in this patient cohort.
Conclusions:
- Accurate differentiation of hypertensive pathways in aortic coarctation is essential for tailoring treatment.
- Targeted management strategies based on the specific pathway can optimize clinical outcomes.
- Further research is needed to refine diagnostic and therapeutic approaches for hypertensive CoA patients.
Abstract:
Patients with aortic coarctation are prone to develop arterial hypertension at various stages throughout life. There are at least three different pathophysiologic pathways: re-stenosis at the aortic isthmus, paradoxical hypertension, and late hypertension at long-term follow-up. As the most common causes of death reported for coarctation patients are linked to hypertension, it is important to differentiate these pathways of hypertension carefully to provide optimal treatment for hypertensive coarctation patients. This review summarizes the actual data about those different pathologic pathways, about how to differentiate them from each other, and how to treat them adequately.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Aortic Regurgitation I: Introduction
Aortic Regurgitation III: Medical Management
Aneurysm II: Clinical Manifestations and Diagnostic Studies
Aneurysm I: Introduction
Aortic Regurgitation IV: Nursing Management

